Topological control of cytokine receptor signaling induces differential effects in hematopoiesis
Although tunable signaling by G protein-coupled receptors can be exploited through medicinal chemistry, a comparable pharmacological approach has been lacking for the modulation of signaling through dimeric receptors, such as those for cytokines. We present a strategy to modulate cytokine receptor s...
Saved in:
Published in | Science (American Association for the Advancement of Science) Vol. 364; no. 6442 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
The American Association for the Advancement of Science
24.05.2019
AAAS |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Although tunable signaling by G protein-coupled receptors can be exploited through medicinal chemistry, a comparable pharmacological approach has been lacking for the modulation of signaling through dimeric receptors, such as those for cytokines. We present a strategy to modulate cytokine receptor signaling output by use of a series of designed C2-symmetric cytokine mimetics, based on the designed ankyrin repeat protein (DARPin) scaffold, that can systematically control erythropoietin receptor (EpoR) dimerization orientation and distance between monomers. We sampled a range of EpoR geometries by varying intermonomer angle and distance, corroborated by several ligand-EpoR complex crystal structures. Across the range, we observed full, partial, and biased agonism as well as stage-selective effects on hematopoiesis. This surrogate ligand strategy opens access to pharmacological modulation of therapeutically important cytokine and growth factor receptor systems. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 USDOE German Research Foundation (DFG) AC02-76SF00515; AC02-06CH11357; AC02-05CH11231; S10OD021832; R01-AI51321; T32HL066987; R01 DK103794; R33 HL120791; 1S10OD012289-01A1 National Institutes of Health (NIH) These authors contributed equally to this work. K.C.G. conceived of the project. K.M., G.U., J.A.F., D.B., and K.C.G. jointly developed the approach for tuning receptor engagement geometry with extendable scaffolds through an iteration of computational design (G.U., J.A.F., and D.B.) and protein engineering (K.M. and K.C.G.). K.M. designed and constructed the DARPin libraries, performed yeast-display selections and affinity maturation, designed and generated the sequences for the extended DARPins, expressed recombinant proteins, biophysically and functionally characterized all the DARPins, and performed immunoprecipitation and protein immunoblotting experiments. G.U. and J.A.F. designed the initial two dimer interfaces. G.U. worked with K.M. to design sequences for the extended DARPin/EpoR complexes and generated three-dimensional models of these complexes. A.R.K. performed the erythropoiesis experiments. K.M., K.M.J., and Y.G. crystallized the protein complexes. K.M.J. and Y.G. collected the crystallography data and determined structures. M.H. performed the TIRF microscopy experiments. Y.M. provided the reference proteins for SPR. R.A.S. assisted with immunoblot analysis. J.P. supervised the TIRF microscopy experiments. V.G.S. supervised the erythropoiesis experiments. K.C.G. and D.B. supervised the project and interpreted the data. K.M. and K.C.G. wrote the manuscript with inputs from all authors. Author contributions |
ISSN: | 0036-8075 1095-9203 |
DOI: | 10.1126/science.aav7532 |